Skip to main content

Oncology

Immunotherapy, Oncology
Overcoming Current Barriers to Using CAR T-Cell Therapy in the Community Setting
Chase Doyle
Chase Doyle
Read More
Neuroendocrine Tumors, Oncology
Combination Immune Blockade Promising in High-Grade Neuroendocrine Tumors: The DART “Basket” Clinical Trial
Phoebe Starr
Phoebe Starr
Read More
Lung Cancer, Oncology
BLU-667, Selective RET Inhibitor, Demonstrates Antitumor Activity in NSCLC with RET Fusion
Wayne Kuznar
Wayne Kuznar
Read More
Oncology, Original Research
Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases
Lonnie Wen, RPh, PhD, Adriana Valderrama, PhD, Mary E. Costantino, PhD, Stacey Simmons, MD
Lonnie Wen, RPh, PhD; Adriana Valderrama, PhD; Mary E. Costantino, PhD; Stacey Simmons, MD
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Read More
FDA Approvals, Oncology Overview, Payers' Guide, Oncology
New Indications Approved by the FDA in 2018 for Oncology Drugs
Dalia Buffery, MA, ABD
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Read More
FDA Approvals, In the News, Lung Cancer, Oncology
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
In the Literature, Oncology
Ibrutinib Superior to Standard Chemoimmunotherapy in Older Patients with CLL
Read More
Page 10 of 27
Results 91 - 100 of 262